Alexandria Real Estate Equities Earnings Call Transcripts
Fiscal Year 2026
-
Operational progress continued despite a tough quarter, with strong asset quality and tenant base, but leasing volume and occupancy declined due to market headwinds. Guidance for FFO per share and dispositions was reaffirmed, while tenant risk and lease expirations remain key watch points.
Fiscal Year 2025
-
Q4 2025 saw record leasing and $1.5B in dispositions, with occupancy at 90.9% and FFO per share at $2.16. 2026 guidance anticipates a temporary dip in occupancy and NOI, with recovery in the second half, and a focus on asset sales and balance sheet strength.
-
Management is executing a strategic shift to focus on mega campuses, reduce non-core assets, and strengthen the balance sheet amid industry headwinds. 2026 guidance reflects lower occupancy and NOI, but the company expects to outperform peers and capitalize on long-term demand drivers like innovation and healthcare needs.
-
Q3 2025 saw solid leasing and strong mega campus performance, but FFO per share and occupancy declined due to industry headwinds, oversupply, and regulatory challenges. Guidance for 2025 was reduced, with a focus on asset sales, capital preservation, and mega campus development.
-
Achieved record leasing with a 466,000 sq ft build-to-suit for a top pharma, driving solid FFO growth and maintaining strong occupancy guidance. Asset recycling and cost discipline continue, while sector resilience is supported by robust M&A and venture funding.
-
1Q25 saw solid financial and operating results, with strong leasing, high rent collections, and continued asset recycling. Guidance was modestly reduced due to known expirations and cautious leasing, but the company remains optimistic about long-term demand and sector resilience.
Fiscal Year 2024
-
FFO per share grew 5.6% in 2024, with strong leasing, capital recycling, and high occupancy. Guidance for 2025 is flat FFO per share, with continued focus on mega campuses, asset recycling, and disciplined capital allocation.
-
Mega campus strategy drives long-term growth, with 2025 FFO per share guidance flat year-over-year due to temporary vacancies. Self-funding through cash flow and asset sales supports $510 million in incremental NOI by 2028, while leasing outperformance and premium rents reinforce competitive advantage.
-
Q3 2024 saw robust financial and operational results, with strong leasing, high occupancy, and significant asset recycling to fund the mega campus strategy. Guidance for FFO per share growth is maintained, and the balance sheet remains strong amid disciplined capital allocation and a resilient life science market.
-
Q2 2024 saw strong FFO and NOI growth, driven by mega campus strategy, high-quality tenants, and robust leasing. Guidance for 2024 FFO per share was reiterated, with a focus on asset recycling and disciplined capital allocation. Liquidity and balance sheet strength remain industry-leading.